Hoxa9 overexpression alone in mouse bone marrow cells leads to a myeloproliferative disorder that progresses to AML around 7 months, suggesting the requirement for additional genetic events prior to AML [17]. Here, HOXA9 is linked to acute myeloid leukemia.